ConjuChem
From Infogalactic: the planetary knowledge core
(Redirected from ConjuChem Biotechnologies)
Lua error in package.lua at line 80: module 'strict' not found.
| Public (TSX has Delisted this Stock) | |
| Industry | Biotechnology |
| Headquarters | Montreal, Quebec, Canada |
|
Key people
|
Mark Perrin |
| Products | Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC) |
|
Number of employees
|
44[citation needed][needs update] |
| Website | www.conjuchem.com |
ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Canada[1] which is credited with inventing the experimental peptide hormone CJC-1295.[2][3]
It employs 45 people, 90% of whom are in research and development.[citation needed][needs update]
References
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
